RNAble
RNAble30About
RNAble is a biotechnology startup focused on developing novel compounds that modulate RNA stability through epitranscriptomics. Their approach targets specific cancers and rare genetic diseases caused by nonsense mutations, aiming to restore protein function.
Frequently asked
What does RNAble do?
RNAble is a biotechnology startup focused on developing novel compounds that modulate RNA stability through epitranscriptomics. Their approach targets specific cancers and rare genetic diseases caused by nonsense mutations, aiming to restore protein function.
What is RNAble's revenue?
StartupHub estimates RNAble's annual revenue at $326K (range $191K to $534K, 64% confidence), based on comparable companies in the sector.
Where is RNAble headquartered?
RNAble is headquartered in Tel Aviv, Israel.
When was RNAble founded?
RNAble was founded in 2021.
What industry does RNAble operate in?
RNAble operates in Life Sciences, RNA-Targeting, Oncology, RNA, Biotech, Drug Discovery.
How many employees does RNAble have?
RNAble has approximately 2 people on record.
What is RNAble's current status?
RNAble's current operating status is: Inactive.
HEADCOUNT
2
DOMAIN RATING
30
Comments
No comments yet. Be the first to share your take.